The North America Vitamin K2 Market would witness market growth of 12.6% CAGR during the forecast period (2024-2031).
The US market dominated the North America Vitamin K2 Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $59.75 millions by 2031. The Canada market is experiencing a CAGR of 15% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 14.1% during (2024 - 2031).
The population's aging is a substantial factor that is driving the demand for vitamin K2. The frequency of age-related health issues, such as cardiovascular and osteoporosis diseases, is increasing in tandem with the growing number of aged people.
Additionally, the elderly are at a significant risk of fractures due to osteoporosis, a condition that is marked by compromised bones. Clinical studies have demonstrated that supplementation with vitamin K2 can substantially reduce bone loss and improve bone strength, making it a valuable tool in the fight against osteoporosis.
North America is a crucial region in the market, characterized by high consumer awareness and a robust dietary supplement industry. The United States and Canada are the primary markets within this region, driving significant growth and demand for vitamin K2 products. The demand for vitamin K2 supplements in North America is significantly influenced by the rising prevalence of chronic diseases, including osteoporosis and cardiovascular disease.
Based on Product Type, the market is segmented into MK-7 and MK-4. Based on Form, the market is segmented into Powder & Crystalline, Capsules & Tablets, and Oils & Liquid. Based on Application, the market is segmented into Health Supplements, Pharmaceutical, and Functional Food & Beverages. Based on Source, the market is segmented into Natural and Synthetic. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The US market dominated the North America Vitamin K2 Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $59.75 millions by 2031. The Canada market is experiencing a CAGR of 15% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 14.1% during (2024 - 2031).
The population's aging is a substantial factor that is driving the demand for vitamin K2. The frequency of age-related health issues, such as cardiovascular and osteoporosis diseases, is increasing in tandem with the growing number of aged people.
Additionally, the elderly are at a significant risk of fractures due to osteoporosis, a condition that is marked by compromised bones. Clinical studies have demonstrated that supplementation with vitamin K2 can substantially reduce bone loss and improve bone strength, making it a valuable tool in the fight against osteoporosis.
North America is a crucial region in the market, characterized by high consumer awareness and a robust dietary supplement industry. The United States and Canada are the primary markets within this region, driving significant growth and demand for vitamin K2 products. The demand for vitamin K2 supplements in North America is significantly influenced by the rising prevalence of chronic diseases, including osteoporosis and cardiovascular disease.
Based on Product Type, the market is segmented into MK-7 and MK-4. Based on Form, the market is segmented into Powder & Crystalline, Capsules & Tablets, and Oils & Liquid. Based on Application, the market is segmented into Health Supplements, Pharmaceutical, and Functional Food & Beverages. Based on Source, the market is segmented into Natural and Synthetic. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Balchem Corporation
- Novozymes A/S (Novo Holdings A/S)
- BASF SE
- Lonza Group Ltd. (Capsugel)
- Haihang Industry Co.,Ltd. (Haihang Group)
- AngelYeast Co., Ltd.
- Kyowa Hakko USA, Inc.
- Lesaffre Group
- DSM Nutritional Products
- Herbalife International, Inc.
Market Report Segmentation
By Product Type- MK-7
- MK-4
- Powder & Crystalline
- Capsules & Tablets
- Oils & Liquid
- Health Supplements
- Pharmaceutical
- Functional Food & Beverages
- Natural
- Synthetic
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Vitamin K2 Market by Product Type
Chapter 5. North America Vitamin K2 Market by Form
Chapter 6. North America Vitamin K2 Market by Application
Chapter 7. North America Vitamin K2 Market by Source
Chapter 8. North America Vitamin K2 Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Balchem Corporation
- Novozymes A/S (Novo Holdings A/S)
- BASF SE
- Lonza Group Ltd. (Capsugel)
- Haihang Industry Co.,Ltd. (Haihang Group)
- AngelYeast Co., Ltd.
- Kyowa Hakko USA, Inc.
- Lesaffre Group
- DSM Nutritional Products
- Herbalife International, Inc.
Methodology
LOADING...
